Child Health and Wellness banner image

UCeed Child Health and Wellness Fund

Canada's first early-stage investment fund for child and maternal health, creating positive health impacts for children and families.

UCeed Child Health is funded by the generosity of our community through the Alberta Children’s Hospital Foundation and their mission to inspire our community to invest in excellence in child health, research and family centred care.

Whether it's making sure that families have access to quality health care and child care, or making sure that our children receive the best educational opportunities we can give them, we must remain committed to these needs because our children are our future.

Blanche Lincoln

Opportunity Fund

UCeed accepts applications on an ongoing basis.

Investment and fund eligibility

Investment 

$50,000 up to $300,000 

Criteria

  • Applicant must have an established relationship with the University of Calgary as a current, past or visiting faculty member, a student, or has licensed or assigned intellectual property developed at the University of Calgary.
  • For-profit enterprise
  • Technology Readiness Level (TRL): Stage 1-9
  • Must be incorporated prior to receipt of funds
  • Minimum one (1) full-time employee within six (6) months of UCeed investment
Child Health

Our Investments

Learn more about our investments and how they are making an impact.

Investment Advisory Group - Child Health and Wellness Fund

Alice Reimer

Alice Reimer

Learn more

Mike Begin

Mike Begin

Learn more

Chen Fong

Chen Fong

Learn more

Derrick Hunter

Derrick Hunter

Learn more

James Lochrie

James Lochrie

Learn more

Zain Kassam

Zain Kassam

Learn more 

meg bregazzi

Meg Bregazzi

Learn more


Clinical Advisory Board

The marketplace success of novel therapeutics, diagnostics, medical devices, and other healthcare products often depends on nuanced factors that require frontline clinician feedback to assess. The Clinical Advisory Board (CAB) is a group of physician volunteers who leverage their networks to connect UCeed Health staff to frontline clinicians who provide feedback on the clinical utility and feasibility of healthcare products and services in development by prospective investee companies. We are deeply grateful for their valuable assistance. 

Marcia Clark

Marcia Clark

Learn more

Derek Exner

Derek Exner

Learn more

James Kellner

James Kellner

Learn more

Lindsay Machan

Lindsay Machan

Learn more


Child Health Fund Portfolios

AazeinTx

AazeinTx

AazeinTx is commercializing a novel, fast-acting, orally delivered compound for the treatment of acute and chronic asthma.

Learn more

chil logo

Child Health Imprints

Child Health Imprints is giving preterm babies a better chance at life with data-monitoring technology that supports clinicians.

Learn more 

Fluid Biomed

Fluid Biomed

Fluid Biomed is revolutionizing the approach to vascular disease by creating the first bioabsorbable brain stent to treat aneurysms. 

Learn more

Nimble Science

Nimble Science

Nimble Science is developing an ingestible medical device capsule that samples small intestine contents for microbiome diagnostic applications obviating the need for invasive endoscopy procedures.

Learn more

Noa Therapeutics logo

Noa Therapeutics

Noa Therapeutics is developing multimodal therapeutics to address the complexity of immune diseases, innovation that will help break the cycle of trial-and-error treatment failures.

Learn more

Trexo Robotics

Trexo Robotics

Trexo Robotics has developed a sophisticated wearable robotic device to provide physiotherapy for children with walking impairments. The device monitors a child’s ability to move their legs with artificial intelligence algorithms and provides a level of assistance that maximizes therapeutic benefit. 

Learn more

Xploro Logo

Xploro Inc.

Xploro Inc. uses artificial intelligence to ease procedural anxiety and reduce stress in children with cancer.

Learn more

Zymedyne logo

Zymedyne

Zymedyne is developing therapeutics for the treatment of chronic pain that targets a recently discovered biological process that is abnormally activated in chronic pain conditions, offering an alternative to opioids.

Learn more